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Rutin is a ﬂavonol glycoside with multiple biological activities and it has been demonstrated that rutin
modulates glucose homeostasis. In pancreatic b-cell, an increase in intracellular calcium concentration
triggers exocytosis and thus insulin secretion. The aim of the study reported herein was to investigate
the effect of rutin associated intracellular pathways on Ca2þ uptake in isolated rat pancreatic islets. We
focused on the acute effects of rutin on in vivo insulin secretion and the in vitro cellular signaling of
pancreatic islets related to this effect. The results show that rutin signiﬁcantly increased glucose-
induced insulin secretion in an in vivo treatment. Moreover, it was demonstrated that rutin stimulated
Ca2þ uptake after 10 min of incubation compared with the respective control group. The involvement
of L-type voltage-dependent Ca2þ channels (L-VDCCs) was evidenced using nifedipine, while the use of
glibenclamide and diazoxide demonstrated that the ATP-sensitive potassium (KATP) channels are not
involved in the rutin action in pancreatic islets. In conclusion, rutin diminish glycemia, potentiate
insulin secretion in vivo and signiﬁcantly stimulates Ca2þ uptake in rat pancreatic islets. A novel
cellular mechanism of action of rutin in Ca2þ uptake on pancreatic b-cells was elucidated. Rutin
modulates Ca2þ uptake in pancreatic islets by opening L-VDCCs, alter intracellular Ca2þ , PLC and PKC
signaling pathways, characterizing KATP channel-independent pathways. These ﬁndings highlight rutin,
a dietary adjuvant, as a potential insulin secretagogue contributing to glucose homeostasis.
& 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Diabetes mellitus is characterized by deranged metabolism
and inappropriate hyperglycemia, resulting from defects in the
secretion and cellular action of insulin. Treatments aimed at
enhancing b-cell function and reducing insulin resistance are
therefore key to improving metabolic control and retarding the
development of diabetic complications (American Diabetes
Association, 2011).
Insulin is the key regulator of glucose uptake in the fed state
and is secreted from b-cells located in the islets of Langerhans in
the pancreas. Glucose is the primary stimulus for insulin secre-
tion, although there are many other metabolic, endocrine, and
neural control mechanisms (Beardsall et al., 2003). Exposure of
the pancreatic b-cell to stimulatory glucose concentrations leads
to the activation of a cascade of reactions, which ends in theax: þ55 48 3721 9672.
lsevier OA license.release of stored insulin. Metabolism of glucose in glycolysis and
the Krebs cycle results in the generation of ATP. The resulting
increase in the cytosolic ATP/ADP-ratio closes ATP-sensitive
potassium (KATP) channels in the plasma membrane, which leads
to depolarization of the cell and inﬂux of Ca2þ through L-type
voltage-dependent Ca2þ channels (L-VDCCs). The increase in
Ca2þ concentration triggers exocytosis and thus insulin secretion
(for review Henquin, 2004).
Different mechanisms of action have been reported for ther-
apeutic drugs used in the treatment of diabetes (Sharif, 2011).
Some pharmacological agents with insulinotropic properties can
directly and positively modulate insulin release (Doyle and Egan,
2003). Recent studies have explored the insulinotropic effects of
natural products (Pinent et al., 2008). Several beneﬁcial effects
have been reported for ﬂavonoids and published data suggest that
there might be direct effects of ﬂavonoids on insulin secretion
(Cazarolli et al., 2008a,b; Folador et al., 2010).
Rutin (quercetin-3-O-rutinoside) is a ﬂavonol glycoside com-
posed of quercetin and the disaccharide rutinose. Many studies
have demonstrated that rutin is a pharmacologically active
phytochemical which exhibits multiple biological activities
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demonstrated that rutin modulates glucose homeostasis. Rutin
can decrease glycemia, increase insulin secretion and inhibit a-
glucosidase (Fernandes et al., 2010; Pereira et al., 2011). Although
the ability of rutin to improve diabetic status has been reported,
studies to determine the exact mechanism of action involved in
the regulation of glucose homeostasis are scarce. Thus, it was
investigated the in vivo effect of rutin on glycemia and insulin
secretion as well as the intracellular pathways on Ca2þ uptake in
isolated pancreatic islets.2. Materials and methods
2.1. Chemicals
Collagenase Type V, 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-
tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM),
(bisindoylmaleimidine IX, 2-{1-[3-(amidinothio)propyl]-1H-indol-
3-yl}-3-(1-methylindol-3-yl) maleimide methanesulfonate salt
(RO-318220), 1-[6-[((17b)-3-methoxyestra-1,3,5[10]-trien-17-yl)a-
mino]hexyl]-1H-pyrrole-2,5-dione (U-73122), rutin, nifedipine,
diazoxide, glibenclamide and bovine serum albumin (BSA) were
purchased from Sigma-Aldrich (St. Louis, MO, USA). [45Ca]CaCl2 (sp.
act. 321 KBq/mg Ca2þ) and Optiphase Hisafe III biodegradable
scintillation liquid were purchased from Perkin-Elmer
(Massachusetts, USA). All other chemicals were of analytical
grade. Enzyme-linked immunosorbent assay (ELISA) for the
quantitative determination of rat insulin (catalog no. EZRMI-
13K) was purchased from Millipore (St Charles, MO, USA).
2.2. Animals
The male Wistar rats (190–220 g) used in this study were bred
in our animal facility and housed in an air-conditioned room
(approximately 22 1C) with controlled lighting on a 12:12 h light/
dark cycle (lights on from 06:00 to 18:00 h). The animals were
maintained with pelleted food (Nuvital, Nuvilab CR1, Curitiba, PR,
Brazil), while tap water was available ad libitum. In the in vivo
treatments rats were deprived of food for at least 16 h but
allowed free access to water. In the in vitro experiments the
animals were not left in fasting. All the animals were monitored
and maintained in accordance with the ethical recommendations
of the Brazilian Veterinary Medicine Council and the Brazilian
College of Animal Experimentation. This study was approved by
the Committee for Ethics in Animal Research of UFSC (Protocol
CEUA PP00398).
2.3. Oral glucose tolerance curve
Fasted rats were divided in groups of four animals for each
treatment. Hyperglycemic Group (as control), normal rats that
received glucose (4 g/kg; 8.9 M p.o. gavage); Glipizide group,
hyperglycemic rats that received glipizide (10 mg/kg; 0.01 M
p.o. gavage); Rutin group, hyperglycemic rats that received rutin
(50 mg/kg; 0.04 M p.o. gavage). The glucose and insulin levels
were measured at zero time (fasted rats). All groups were loaded
with glucose 30 min after rutin or glipizide treatment. So, glyce-
mia and insulin levels were determined at 15, 30, 60 min after
glucose overload (Folador et al., 2010).
2.4. Insulin serum measurements
The insulin levels were determined at 450 nm with an ELISA
plate reader (Organon Teknika, Roseland, NJ, USA) by interpola-
tion from a standard curve. Samples were analyzed in duplicateand results were expressed as ng per ml of insulin serum. The
incremental areas under the response curves (AUCs) were calcu-
lated. The insulinogenic index (II) was calculated as the ratio
between the AUCinsulin and AUCglucose (from zero to 60 min)
(Frederico et al., 2012).2.5. Rat islet isolation and Ca2þ uptake experiments
Islets were isolated by collagenase digestion as previously
described by Lacy and Kostianovsky (1967), with minor modiﬁca-
tions (Frederico et al., 2012). The islets were then incubated for
10 min in KRb–HEPES buffer containing 0.1 mCi/ml 45Ca2þ at
37 1C, pH 7.4 and gassed with O2:CO2 (95:5; v/v) without
(control) or with rutin. In some experiments channel blockers or
kinase inhibitors were added during the last 15 min before
the treatment and maintained during the entire incubation
period (see ﬁgure legends). The following drugs were used:
glibenclamide (60 mM), diazoxide (100 mM), nifedipine (1 mM),
U-73122 (1 mM) (Frederico et al., 2012), BAPTA-AM (50 mM), RO
31-8220 (20 mM), (Zanatta et al., 2011). Cold buffer with lantha-
num chloride (10 mM) was added to the samples at the end of
incubation in order to stop Ca2þ ﬂuxes (Batra and Sjo¨gren, 1983).
Aliquots were taken from each sample for radioactivity measure-
ment in scintillation liquid in an LKB rack beta liquid scintillation
spectrometer (model LS 6500; Multi-Purpose Scintillation
Counter-Beckman Coulter, Boston, USA) and were used for protein
quantiﬁcation by the Lowry method (1951).2.6. Data and statistical analysis
Data were expressed as mean7S.E.M. One-way analysis of
variance (ANOVA) was carried out followed by the Bonferroni post
hoc or unpaired Student’s t-test to determine the signiﬁcance of
differences between groups. Differences were considered to be
signiﬁcant at Po0.05.3. Results
3.1. Effect of rutin on oral glucose tolerance curve
Fig. 1A shows the acute effect of rutin on serum glucose levels.
Fifteen minutes after the glucose loading the glycemia was
signiﬁcantly increased when compared with zero time on the
hyperglycemic control group. The sulfonylurea glipizide (10 mg/
kg), an oral hypoglycemic agent, was used as a positive
control and produced a typical serum glucose lowering during
all periods analyzed (from 15 to 60 min) compared to the
hyperglycemic group. With the oral administration of rutin
(50 mg/kg) the serum glucose levels were also signiﬁcantly
reduced at 15, 30 and 60 min around 21, 24 and 17% respectively
in hyperglycemic rats.
Serum insulin levels in fasted rats were determined after an
oral glucose loading (4 g/kg) as shown in Fig. 1B. As expected, a
sulfonylurea agent, glipizide, stimulated insulin secretion by
295, 152 and 191% at 15, 30 and 60 min after glucose loading,
respectively, compared to the hyperglycemic control group.
The rutin (50 mg/kg) potentiated insulin secretion induced by
glucose about 155% at 15 min after glucose loading. The in vivo
treatment with rutin resulted in 1.5-fold increase in II (0.64 ng/
mg), compared with hyperglycemic control group (0.44 ng/mg)
(Fig. 1C)
Fig. 1. Acute effect of rutin on (A) serum glucose levels, (B) insulin levels, and
(C) insulinogenic index (II; ng/mg). Values are expressed as mean7S.E.M.; n¼4 in
duplicate for each treatment. Statistically signiﬁcant difference compared to the
corresponding hyperglycemic group, ***Po0.001; **Po0.01 and *Po0.05.
Fig. 2. Time-course of rutin effect on 45Ca2þ uptake in isolated rat pancreatic
islets. The pancreatic islets were pre-incubated for 60 min in the presence of
0.1 mCi/ml of 45Ca2þ . The pancreatic islets were incubated with/without 1014 M
rutin for 1, 5 and 10 min. Values are means7S.E.M. (quadruplicate analysis for
each group). **Po0.01 compared with control group.
Fig. 3. Inﬂuence of Kþ channel on stimulatory effect of rutin in 45Ca2þ uptake in
isolated rat pancreatic islets. The pancreatic islets were pre-incubated for 60 min
with 0.1 mCi/ml of 45Ca2þ . In the last 15 min of pre-incubation (A), glibenclamide
60 mM (blocker) and (B), diazoxide 100 mM (activator) was added to the incuba-
tion medium. The tissue was then treated with or without 1014 M rutin for
10 min (incubation). Values are means7S.E.M. (quadruplicate analysis for each
group). *Po0.05, **Po0.01 and ***Po0.001 compared to control group. #Po0.05
compared to rutin group.
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isolated rat pancreatic islets
Calcium is well known to be involved in insulin secretion by b-
cells. Thus, in order to study the mechanism of action of rutin on
insulin secretion, in vitro studies were carried out. After the Ca2þ
equilibrium obtained through 60 min of islet incubation with
45Ca2þ , Ca2þ uptake was then monitored for 1, 5 and 10 min
without stimuli (control) and in the presence of rutin (1014 M),
in isolated pancreatic islets. The treatment with rutin augmented
the Ca2þ uptake after 10 min (58%). Although the ascendant Ca2þ
uptake proﬁle observed on Fig. 2, no signiﬁcant effect of rutin on
Ca2þ uptake was detected at 1 and 5 min.
To study the involvement of KATP channels in the stimulatory
effect of rutin on Ca2þ uptake, glibenclamide a Kþ channel
blocker and, diazoxide a Kþ channel activator, were used. As
expected, the treatment with glibenclamide signiﬁcantly
increased the Ca2þ uptake in isolated pancreatic islets after
10 min. Also, in the presence of glibenclamide an additional effect
on Ca2þ uptake stimulated by rutin was observed (Fig. 3A).
Furthermore, Fig. 3B shows that diazoxide signiﬁcantly decreased
the Ca2þ uptake. On the other hand, the presence of diazoxide did
not inﬂuence the stimulatory effect of rutin on Ca2þ uptake in
isolated pancreatic islets (Fig. 3B).
In addition to verify the participation of L-VDCCs in the
mechanism involved in the stimulatory effect of rutin on 45Ca2þ
uptake, nifedipine was used. Fig. 4A shows that nifedipine did not
change the basal level of Ca2þ uptake. However, nifedipine
inhibited the effect of rutin.The inﬂuence of intracellular Ca2þ in the stimulatory effect of
rutin on Ca2þ uptake was investigated using BAPTA-AM, an
intracellular Ca2þ chelator. Fig. 4B shows that BAPTA-AM did
not alter the basal level of Ca2þ uptake. However, in the presence
of BAPTA-AM the stimulatory effect of rutin on 45Ca2þ uptake
was inhibited.
Glucose-induced insulin release is controlled by a balance
between protein phosphorylation and dephosphorylation
(Ammala et al., 1994) and involves the activation of protein
kinase C (PKC) (Mendez et al., 2003). Thus, the involvement of
phospholipase C (PLC) and protein kinase C (PKC) in rutin-induced
Ca2þ uptake was investigated. To this aim, isolated pancreatic
islets were incubated in the presence or absence of rutin with/
without speciﬁc inhibitors—U-73122 and RO-318220. These
Fig. 4. Inﬂuence of L-type voltage-dependent Ca2þ channel (L-VDCC) and intra-
cellular Ca2þon stimulatory effect of rutin in 45Ca2þ uptake in isolated rat
pancreatic islets. The pancreatic islets were pre-incubated for 60 min with
0.1 mCi/ml of 45Ca2þ . In the last 15 min of pre-incubation (A), nifedipine 1 mM
(L-VDCC blocker) and (B), BAPTA-AM 50 mM (intracellular Ca2þ chelator) were
added to the incubation medium. The tissue was then treated with or without
1014 M rutin for 10 min (incubation). Values are means7S.E.M. (quadruplicate
analysis for each group). ***P o0.001 compared to control group. #Po0.05
compared to rutin group.
Fig. 5. Inﬂuence of PLC and PKC on stimulatory effect of rutin in 45Ca2þ uptake in
isolated rat pancreatic islets. The pancreatic islets were pre-incubated for 60 min
with 0.1 mCi/ml of 45Ca2þ . In the last 15 min of pre-incubation, (A), U-73122 1 mM
(PLC inhibitor) and (B), RO-318220 1 mM (PKC inhibitor) was added to the
incubation medium. The tissue was then treated with or without 1014 M rutin
for 10 min (incubation). Values are means7S.E.M. (quadruplicate analysis
for each group). **Po0.01 compared to control group. #Po0.05 compared to
rutin group.
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level of Ca2þ uptake. On the other hand, U-73122 and RO-318220
completely prevented the rutin stimulatory effect (Fig. 5A and B).4. Discussion
In the study reported herein, rutin as much as glipizide was
effective on serum glucose lowering after acute oral treatment in
hyperglycemic rats. Pereira et al. (2011) also evidenced the
antihyperglycemic effect of rutin (50 mg/kg) in the similar experi-
mental model. Numerous reports have demonstrated that ﬂavo-
noids can act as insulin secretagogues (Cazarolli et al., 2008a,b;
Folador et al., 2010). Here, rutin signiﬁcantly increased insulin
secretion with an II about 56% of the glipizide effect.
Kamalakkannan and Prince (2006) also demonstrated that rutin
increase insulin levels after in vivo treatment. The authors
suggested that rutin act as an antioxidant compound protecting
b-cells in diabetic rats.
It is reported that the most important pathway for quantitative
insulin release from islet interstitial is regulated by ionic Ca2þ
(for review Henquin, 2004). Our results showed that rutin is able
to alter Ca2þ uptake in isolated pancreatic islets (Fig. 2). In
agreement with Hii and Howell (1985), the exposure of rat
isolated islets to certain ﬂavonoids such as epicatechin or quer-
cetin (aglycone of rutin) enhance insulin release and increase the
intracellular Ca2þ .
Glibenclamide directly blocks KATP channels of the b-cell
membrane and increase intracellular Ca2þ . In our experimental
conditions, as expected glibenclamide increased Ca2þ uptake in
pancreatic islet. In addition, when rutin was present into incuba-
tion medium, an additive effect on Ca2þ uptake was observed.
The co-treatment with diazoxide did not alter the stimulatory
effect of rutin on Ca2þ uptake, suggesting that rutin effect is
independent of plasma membrane KATP channels activation. In
agreement with these data, Adisakwattana et al. (2011) demon-
strated that a cinnamic acid derivative, p-methoxycinnamic acid,
stimulated insulin secretion from pancreatic b-cells by increasing
Ca2þ inﬂux via the L-VDCC, but not through the closure of KATP
channels.
It is well known that the depolarization of the plasma
membrane induced by sulfonylureas activates L-VDCCs in pan-
creatic islets (for review Yang and Berggren, 2005). The stimula-
tory effect of rutin on the Ca2þ uptake was abolished in the
presence of nifedipine. Moreover, the stimulatory effect of rutin
was reduced by the presence of an intracellular Ca2þ chelator,
BAPTA-AM. The calcium dynamic is critical since it depends on
the equilibrium of Ca2þ transport and buffer cellular systems
(Friel and Chiel, 2008). So, it is difﬁcult to predict how rutin
handles the Ca2þ levels. However our results indicate a strong
inﬂuence of intracellular Ca2þ on stimulatory effect of rutin on
Ca2þ uptake.
The results presented so far suggest that increased Ca2þ
uptake by rutin can be independent of KATP channels. Following,
Ca2þ uptake can also be produced or enhanced by mechanisms
that are independent of plasma membrane depolarization
induced by KATP channel activity (Henquin, 2004; MacDonald
and Wheeler, 2003). Fig. 5A showed that in the presence of a PLC
inhibitor (U-73122) the stimulatory effect on Ca2þ uptake gen-
erated by rutin was blocked. In addition, other studies have
indicated that the PLC plays a signiﬁcant role in maintaining the
quantity of intracellular Ca2þ (Jing et al., 2005; Yang and
Berggren, 2005). In a whole, the effect of RO-318220 on Ca2þ
uptake stimulated by rutin and PKC involvement is according
with that reported by Arkhammar et al. (1994) concerning with
the Ca2þ uptake through VDCC that diminish dramatically after
deprivation of PKC, in mouse pancreatic b-cells.
Taking together, our results point that rutin may be acting
through two signaling pathways to increase Ca2þ uptake in b-
cells. One pathway through the activation of Ca2þ channels
directly, since that Ca2þ also acts as cofactor for the activation
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by activation of Gq protein-coupled receptors (Ahre´n, 2009).5. Conclusions
The rutin diminish glycemia, potentiate insulin secretion
in vivo and signiﬁcantly stimulates Ca2þ uptake in rat pancreatic
islets. A novel cellular mechanism of action of rutin in Ca2þ
uptake on pancreatic b-cells was elucidated. Rutin modulates
Ca2þ uptake in pancreatic islets by opening L-VDCC, alter intra-
cellular Ca2þ , PLC and PKC signaling pathways, characterizing
KATP channel-independent pathways. These ﬁnds highlight rutin,
a dietary adjuvant, as a potential insulin secretagogue contribut-
ing to glucose homeostasis.Acknowledgments
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